8
Jul 2026
A few tears may someday reveal important clues about a person's neurological health. Researchers reporting in ACS Omega developed a low-cost electrochemical sensor designed to detect dopamine, a neurotransmitter involved in movement, learning, motivation, and emotional regulation.
8
Jul 2026
A project led by the University of Barcelona, GenAIMIX, will develop new generative artificial intelligence (AI) assistants for hospitals with limited resources, with the aim of improving healthcare in countries with limited financial resources.
8
Jul 2026
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders.
8
Jul 2026
An international team has published a new guideline for diagnosing and treating the rare genetic disease. It serves as a tool for everyone who treats and cares for patients affected by it.
8
Jul 2026
Gabriel Lázaro-Muñoz, PhD, JD, and Amanda R. Merner, PhD, of the Health Technology Performance Lab within the Mass General Brigham Neuroscience Institute, are the authors of a paper published in The American Journal of Psychiatry, "Implantable Neuromodulation Devices in Psychiatry: Human Fidelity and Implementation Challenges."
8
Jul 2026
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease.
8
Jul 2026
A recent review of published research provides some evidence that a small but noteworthy minority of transmasculine people (trans, nonbinary, and other gender expansive people who were assigned female at birth) have pregnancies (6%–9%) and children (4%–9%), including after transition.
8
Jul 2026
Alcohol use and smoking were linked to breast cancer and atrial fibrillation/flutter in women ages 55 years and older in multiple regions of the world, according to new, independent research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
8
Jul 2026
Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1 million people with asthma are now using combination inhalers following the joint 2024 asthma guidelines from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN).
8
Jul 2026
Bedfont® Scientific Limited, an innovative leader in breath analysis and Fractional exhaled Nitric Oxide (FeNO) testing for asthma care with the NObreath®, welcomes the news that over 1 million people with asthma are now using combination inhalers following the joint 2024 asthma guidelines from the National Institute for Care Excellence (NICE), the British Thoracic Society (BTS), and the Scottish Intercollegiate Guidelines Network (SIGN).
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
